Ela Medical launches third-generation defibrillator
This article was originally published in Clinica
Executive Summary
Synthelabo's pacemaker subsidiary Ela Medical has launched a third generation implantable dual-chamber defibrillator in Europe, that could cut the number of unnecessary shocks given to patients. The Defender III has an improved version of the company's PARAD arrhythmia detection algorithm that is specially designed for patients with paroxysmal atrial fibrillation.